We are live on
!
Find out more
II
IFM Investors Portfolio holdings
AUM
$15.1B
1-Year Est. Return
40.57%
This Fund
S&P 500
This Quarter
Est. Return
+9.83%
1 Year Est. Return
+40.57%
3 Year Est. Return
+130.57%
5 Year Est. Return
+172.93%
10 Year Est. Return
–
AUM
$2.83B
AUM Growth
+$129M
(+4.8%)
Cap. Flow
-$101M
Cap. Flow
% of AUM
-3.55%
Top 10 Holdings %
Top 10 Hldgs %
22.2%
Holding
627
New
19
Increased
62
Reduced
525
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$3.7M |
| 2 |
Blackstone
BX
|
+$3.17M |
| 3 |
Truist Financial
TFC
|
+$3.01M |
| 4 |
RingCentral
RNG
|
+$1.16M |
| 5 |
Insulet
PODD
|
+$972K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$7.53M |
| 2 |
Apple
AAPL
|
+$6.48M |
| 3 |
Microsoft
MSFT
|
+$4.04M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$3.33M |
| 5 |
Amazon
AMZN
|
+$2.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.88% |
| 2 | Financials | 15.63% |
| 3 | Healthcare | 13.73% |
| 4 | Communication Services | 10.53% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Dollar Tree
DLTR
$24.8B
| $2.34M | 0.08% |
24,895
-1,012
| -4% | -$106K |
|
252
Synchrony
SYF
$25.5B
| $2.33M | 0.08% |
64,741
-4,979
| -7% | -$178K |
|
253
Idexx Laboratories
IDXX
$46.3B
| $2.33M | 0.08% |
8,921
-368
| -4% | -$97K |
|
254
Carnival Corporation Ltd
CCL
$39.3B
| $2.32M | 0.08% |
45,630
-2,389
| -5% | -$107K |
|
255
Ametek
AME
$58.2B
| $2.3M | 0.08% |
23,023
-1,851
| -7% | -$175K |
|
256
Clorox
CLX
$12.8B
| $2.29M | 0.08% |
14,943
+1,831
| +14% | +$274K |
|
|
SPLK
257
DELISTED
Splunk Inc
SPLK
| $2.27M | 0.08% |
15,169
-682
| -4% | -$89.5K |
|
|
XYZ
258
Block Inc
XYZ
$47.5B
| $2.27M | 0.08% |
36,270
-1,129
| -3% | -$72.1K |
|
259
Kraft Heinz
KHC
$29.8B
| $2.26M | 0.08% |
70,242
-2,505
| -3% | -$75.9K |
|
260
Best Buy
BBY
$16.9B
| $2.25M | 0.08% |
25,674
-2,053
| -7% | -$157K |
|
261
CDW
CDW
$17.6B
| $2.25M | 0.08% |
15,742
-936
| -6% | -$124K |
|
262
Brown-Forman Class B
BF.B
$13.1B
| $2.22M | 0.08% |
32,897
-1,730
| -5% | -$112K |
|
263
Hewlett Packard
HPE
$68.9B
| $2.22M | 0.08% |
140,019
-9,102
| -6% | -$145K |
|
264
Synopsys
SNPS
$79B
| $2.2M | 0.08% |
15,811
-1,182
| -7% | -$162K |
|
265
Northern Trust
NTRS
$33.4B
| $2.19M | 0.08% |
20,659
-1,372
| -6% | -$140K |
|
266
Corteva
CTVA
$50.6B
| $2.19M | 0.08% |
74,146
-5,338
| -7% | -$141K |
|
267
Ventas
VTR
$47.4B
| $2.18M | 0.08% |
37,825
-995
| -3% | -$62.5K |
|
268
American Water Works
AWK
$26.6B
| $2.17M | 0.08% |
17,697
-1,269
| -7% | -$154K |
|
269
ResMed
RMD
$29.6B
| $2.17M | 0.08% |
13,975
-1,122
| -7% | -$162K |
|
270
M&T Bank
MTB
$35.8B
| $2.17M | 0.08% |
12,755
-612
| -5% | -$99.3K |
|
271
MSCI
MSCI
$41.5B
| $2.16M | 0.08% |
8,350
-508
| -6% | -$124K |
|
272
TransUnion
TRU
$15.4B
| $2.14M | 0.08% |
24,980
+3,574
| +17% | +$298K |
|
|
ANSS
273
DELISTED
Ansys
ANSS
| $2.13M | 0.08% |
8,296
-455
| -5% | -$108K |
|
274
KeyCorp
KEY
$24.1B
| $2.13M | 0.08% |
105,491
-7,534
| -7% | -$142K |
|
275
DexCom
DXCM
$31.1B
| $2.13M | 0.08% |
39,020
+2,080
| +6% | +$98.7K |
|
Similar funds
IA
AT
UM
FCAS
RFC
GF
IFM Investors's Q4 2019 Portfolio in Review
As of Q4 2019, IFM Investors held 627 positions worth $2.83B, up 4.8% from $2.71B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
IFM Investors withdrew a net $101M in Q4 2019, closing 17 positions and reducing 525 holdings. Its most notable exit was Celgene Corp, an estimated $7.53M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, IFM Investors opened a new position in Blackstone worth $3.42M.
- IFM Investors's largest Q4 2019 buy was Blackstone: 61,161 shares worth $3.42M.
- IFM Investors added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.7M increase.
- IFM Investors's biggest Q4 2019 reduction was Apple, cutting an estimated $6.48M.
- IFM Investors fully exited Celgene Corp in Q4 2019, selling an estimated $7.53M.
- IFM Investors's ten largest holdings make up 22% of its $2.83B portfolio in Q4 2019.
- IFM Investors opened 19 new positions and closed 17 in Q4 2019.
- IFM Investors's portfolio value rose 4.8% quarter-over-quarter to $2.83B.
Based on IFM Investors's 13F filing for Q4 2019, filed 13 Jan 2020.